Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2019.

Li X, Feng X, Sun X, Hou N, Han F, Liu Y. · 2022

Read Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2019. by Li X, Feng X, Sun X, Hou N, Han F, Liu Y. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9588915.txt.

Introduction

Li and co-authors track the global burden of Alzheimer's disease and other dementias from 1990 to 2019. The count draws on the Global Burden of Disease 2019 database. Ageing populations make dementia a fast growing health concern. Sound trend data can steer health plans and budgets.

Case counts rose steeply across the three decades. Incidence climbed by 147.95% and prevalence by 160.84% in that span. Age-standardized rates also rose for both sexes. Rates in women stayed higher than in men throughout. Yet the rises ran faster in men than in women. Burden tracked the sociodemographic index of each country. Richer, older regions carried the heaviest loads. Smoking was the top risk factor in men. Obesity was the top risk factor in women.

Catalog record

CREATORLi X, Feng X, Sun X, Hou N, Han F, Liu Y.
YEAR2022
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC9588915

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019 By Xue Li, Xiaojin Feng, Xiaodong Sun, Ningning Hou, Fang Han, Yongping Liu Published in: Frontiers in Aging Neuroscience DOI: 10.3389/fnagi.2022.937486 ABSTRACT Background With the increase in the aging population worldwide, Alzheimer's disease has become a rapidly increasing public health concern. Monitoring the dementia disease burden will support health development strategies by providing scientific data. Methods Based on the data obtained from the 2019 Global Burden of Disease (GBD) database, the numbers and age-standardized rates (ASRs) of incidence, prevalence, death, and disability-adjusted life-years (DALYs) of Alzheimer's disease and other dementias from 1990 to 2019 were analyzed. Calculated estimated annual percentage changes (EAPCs) and Joinpoint regression analyses were performed to evaluate the trends during this period. We also evaluated the correlations between the epidemiology and the sociodemographic index (SDI), an indicator to evaluate the level of social development in a country or region considering the education rate, economic situation, and total fertility rate. Results From 1990 to 2019, the incidence and prevalence of Alzheimer's disease and other dementias increased by 147.95 and 160.84%, respectively. The ASR of incidence, prevalence, death, and DALYs in both men and women consistently increased over the study period. All the ASRs in women were consistently higher than those in men, but the increases were more pronounced in men. In addition, the ASRs of incidence, prevalence, and DALYs were positively correlated with the SDI. Moreover, the proportion of patients over 70 years old with dementia was also positively correlated with the SDI level. Smoking was a major risk factor for the disease burden of dementia in men, while obesity was the major risk factor for women. Conclusion From 1990 to 2019, the Alzheimer's disease burden increased worldwide. This trend was more serious in high-SDI areas, especially among elderly populations in high-SDI areas, who should receive additional attention. Policy-makers should take steps to reverse this situation. Notably, women were at a higher risk for the disease, but the risk in men showed a faster increase. We should give attention to the aging population, attach importance to interventions targeting dementia risk factors, and formulate action plans to address the increasing incidence of dementia. INTRODUCTION Dementia is a syndrome, with the most common type being Alzheimer's disease (Oh and Rabins, 2019). Clinically, Alzheimer's disease is mainly characterized by comprehensive dementia, including memory disorder, cognitive disorder, executive dysfunction, and personality and behavior changes, and is accompanied by mental disorder symptoms in most patients (Lyketsos et al., 2011). Although these symptoms can be temporarily relieved by detailed care and medication, there are no specific measures to prevent or cure Alzheimer's disease (Srivastava et al., 2021). Dementia mainly occurs in older age groups, and the incidence and prevalence rates increase with increasing age; this trend is more common in low- and middle-income countries and regions (Gao and Liu, 2021). It has become an increasingly serious global public health problem, imposing serious economic and disease burdens on societies and families (GBD 2016 Dementia Collaborators, 2019). It has been reported that the global number of people with dementia has increased to 43.8 million in 2016, an increase of 117% compared with 20.3 million in 1990 (GBD 2016 Dementia Collaborators, 2019). It is estimated that, by 2050, there will be 152 million people with Alzheimer's disease and other dementias (GBD 2019 Dementia Forecasting Collaborators, 2022). Given that the onset is closely related to age, the disease burden is expected to increase with the aging population and increased life expectancy. In addition to age, a recent study in the Lancet Commission has reported other risk factors for dementia, including hypertension, obesity, diabetes, physical inactivity, hearing loss, smoking, depression, low level of education, and a low socialization frequency (Livingston et al., 2017). With progressive studies, excessive alcohol intake, brain damage, and air pollution were also added to the list of risk factors for Alzheimer's disease and dementia by 2020 (Livingston et al., 2020). Although no effective measures exist to prevent or cure the onset of dementia, growing evidence has demonstrated that more than a third of dementia cases could be prevented or delayed by managing controllable risk factors (Gauthier et al., 2016; Livingston et al., 2017). Monitoring the risk factors and the epidemiological trends of Alzheimer's disease and dementia over time is critical for the global prevention of dementia (GBD 2016 Dementia Collaborators, 2019). According to the data from 1990 to 2016 in the GBD database, the most recently published study in Lancet Neurology demonstrated a growing challenge to healthcare systems worldwide (GBD 2016 Dementia Collaborators, 2019). However, the temporal trends of the following 3 years (from 2017 to 2019) were absent. In the present study, we tracked the epidemiology trends of the past three decades from 1990 to 2019 based on the data in GBD 2019, hoping to potentially inform efforts toward preventing dementia. The Global Burden of Disease, Injury, and Risk Factors Study (GBD) 2019 leveraged available data from the literature, medical institution records, and publicly available databases and used Bayesian regression models to perform a systematic and scientific analysis of the epidemiological data of 204 countries and regions; analyses were performed for both genders, and the GBD 2019 covered 369 diseases, with corresponding age-standardized rates of incidence, prevalence, death, and DALYs (GBD 2019 Diseases Injuries Collaborators, 2020). DALYs refer to the number of healthy years of life lost from the development of morbidity to death and are the most representative and widely used indicators of disease burden (Murray et al., 2012). The GBD 2019 also included 87 common disease risks, contributing to the understanding of dementia as a complex disease (GBD 2019 Risk Factors Collaborators, 2020). We analyzed the changing trends of Alzheimer's disease and other dementias using data from the GBD 2019; described the global distribution characteristics of dementia by gender, age, country, and region; and comprehensively analyzed the risks of dementia in different countries and regions. We hope that this study will aid in the development of targeted policies and control of dementia to improve people's health and guide the rational allocation of medical resources. MATERIALS AND METHODS Data sources The specific data analyzed in the current study were obtained from the most recently updated online Global Health Data Exchange (GHDx) Query Tool (http://ghdx.healthdata.org/gbd-results-tool) on 20 March 2020. The detailed methods followed those of the GBD 2019 (GBD 2017 DALYs HALE Collaborators, 2018; GBD 2017 Disease Injury Incidence Prevalence Collaborators, 2018; GBD 2017 Mortality Collaborators, 2018). The GBD 2019 analysis of risk factors followed the general framework of comparative risk assessment (CRA), including the inclusion of risk-outcome pairs, relative risk estimates, estimation of exposure levels and distributions, determination of counterfactual levels of exposure, calculation of population attribution scores and attribution burdens, and estimation of the mediating role of different risk factors through other risk factors (GBD 2019 Risk Factors Collaborators, 2020). The detailed methods refer to previous studies (GBD 2019 Risk Factors Collaborators, 2020). We analyzed the trends of incident cases, prevalent cases, deaths, and DALYs due to Alzheimer's disease and other dementias from 1990 to 2019 at the global, regional, and state levels. Differences among sexes and age ranges were also assessed. Age-standardized rates (ASRs) were used to prevent confounding

Read the complete text